Procter & Gamble (NYSE:PG) Trading Up 0.3% – Should You Buy?

The Procter & Gamble Company (NYSE:PGGet Free Report)’s stock price traded up 0.3% on Tuesday . The stock traded as high as $168.70 and last traded at $168.63. 823,754 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 6,731,215 shares. The stock had previously closed at $168.11.

Analysts Set New Price Targets

Several brokerages recently issued reports on PG. DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a research note on Thursday, August 29th. Morgan Stanley upped their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. DA Davidson upgraded Procter & Gamble from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $160.00 to $209.00 in a research report on Monday, November 25th. JPMorgan Chase & Co. upped their target price on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $180.45.

Check Out Our Latest Research Report on Procter & Gamble

Procter & Gamble Stock Up 0.5 %

The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $397.86 billion, a PE ratio of 29.13, a PEG ratio of 3.70 and a beta of 0.44. The business has a fifty day moving average of $170.71 and a 200 day moving average of $169.81.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the prior year, the firm earned $1.83 EPS. The firm’s revenue for the quarter was down .6% on a year-over-year basis. Equities research analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.38%. Procter & Gamble’s payout ratio is 69.31%.

Insider Buying and Selling at Procter & Gamble

In other news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the sale, the insider now directly owns 19,341 shares in the company, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 83,080 shares of company stock valued at $14,629,038 in the last quarter. Corporate insiders own 0.18% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

Hedge funds and other institutional investors have recently made changes to their positions in the business. Concurrent Investment Advisors LLC boosted its stake in Procter & Gamble by 4.5% in the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after acquiring an additional 4,035 shares in the last quarter. Copley Financial Group Inc. acquired a new stake in shares of Procter & Gamble in the 3rd quarter valued at about $668,000. Synovus Financial Corp grew its stake in Procter & Gamble by 3.4% during the 3rd quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock worth $32,065,000 after buying an additional 6,077 shares during the last quarter. Radnor Capital Management LLC acquired a new position in Procter & Gamble during the third quarter worth approximately $5,705,000. Finally, Welch Group LLC lifted its stake in Procter & Gamble by 0.9% in the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after buying an additional 2,990 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.